• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Stroke Prevention in Atrial Fibrillation in Patients With Chronic Kidney Disease.

作者信息

Qamar Arman, Bhatt Deepak L

机构信息

From Brigham and Women's Hospital Heart & Vascular Center and Harvard Medical School, Boston, MA.

出版信息

Circulation. 2016 Apr 12;133(15):1512-5. doi: 10.1161/CIRCULATIONAHA.115.018549.

DOI:10.1161/CIRCULATIONAHA.115.018549
PMID:27067086
Abstract
摘要

相似文献

1
Stroke Prevention in Atrial Fibrillation in Patients With Chronic Kidney Disease.慢性肾脏病患者心房颤动的卒中预防
Circulation. 2016 Apr 12;133(15):1512-5. doi: 10.1161/CIRCULATIONAHA.115.018549.
2
Preventing stroke and systemic embolism in renal patients with atrial fibrillation: focus on anticoagulation.预防房颤肾病患者的中风和全身性栓塞：聚焦抗凝治疗。
Contrib Nephrol. 2013;179:81-91. doi: 10.1159/000346726. Epub 2013 May 3.
3
An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation.达比加群、利伐沙班和阿哌沙班治疗心房颤动的间接比较。
Thromb Haemost. 2012 Sep;108(3):476-84. doi: 10.1160/TH12-02-0093. Epub 2012 Jun 28.
4
Stroke risk and efficacy of apixaban in atrial fibrillation patients with moderate chronic kidney disease.房颤伴中度慢性肾脏病患者的卒中风险和艾吡沙班疗效。
J Stroke Cerebrovasc Dis. 2012 Aug;21(6):429-35. doi: 10.1016/j.jstrokecerebrovasdis.2012.05.007.
5
Is Apixaban (Eliquis) the "ideal" anticoagulant to replace warfarin for stroke prevention in atrial fibrillation?阿哌沙班（艾乐妥）是替代华法林用于预防房颤患者中风的“理想”抗凝药吗？
S D Med. 2013 Jan;66(1):20-1.
6
Apixaban for the prevention of stroke in atrial fibrillation.阿哌沙班用于预防心房颤动中的卒中
Expert Rev Cardiovasc Ther. 2012 Feb;10(2):143-9. doi: 10.1586/erc.11.187.
7
Mixed treatment comparison meta-analysis of aspirin, warfarin, and new anticoagulants for stroke prevention in patients with nonvalvular atrial fibrillation.非瓣膜性心房颤动患者预防卒中的阿司匹林、华法林和新型抗凝药的混合治疗比较荟萃分析。
Clin Ther. 2013 Jul;35(7):967-984.e2. doi: 10.1016/j.clinthera.2013.05.011.
8
[New oral anticoagulants in patients with atrial fibrillation in a urban health center].[城市医疗中心心房颤动患者的新型口服抗凝剂]
Med Clin (Barc). 2016 Mar 18;146(6):280-1. doi: 10.1016/j.medcli.2015.06.016. Epub 2015 Sep 4.
9
Apixaban versus warfarin in patients with atrial fibrillation according to prior warfarin use: results from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial.依先前华法林使用情况评估的房颤患者中阿哌沙班与华法林的比较：来自房颤患者中应用阿哌沙班减少卒中和其他血栓栓塞事件的临床试验结果。
Am Heart J. 2013 Sep;166(3):549-58. doi: 10.1016/j.ahj.2013.05.016. Epub 2013 Jul 25.
10
[Atrial fibrillation. Apixaban reduces stroke risk].
MMW Fortschr Med. 2013 Mar 7;155(4):70-1.

引用本文的文献

1
Current Gaps in the Provision of Safe and Effective Anticoagulation in Atrial Fibrillation and the Potential for Factor XI-Directed Therapeutics.当前在心房颤动中提供安全有效的抗凝治疗方面存在的差距以及 XI 因子导向治疗的潜力。
Crit Pathw Cardiol. 2024 Jun 1;23(2):47-57. doi: 10.1097/HPC.0000000000000351. Epub 2024 Feb 21.
2
Real-world Experience in Managing Atrial Fibrillation in Patients with Renal Impairment; Rivaroxaban versus Warfarin.肾功能损害患者心房颤动管理的真实世界经验；利伐沙班与华法林对比
Heart Views. 2023 Jul-Sep;24(3):136-140. doi: 10.4103/heartviews.heartviews_117_22. Epub 2023 Jul 5.
3
Role of Anticoagulants for Stroke Prevention in Low-Risk Population Having Atrial Fibrillation and Chronic Kidney Disease: A Systematic Review.
抗凝剂在患有心房颤动和慢性肾脏病的低风险人群中预防中风的作用：一项系统评价。
Cureus. 2022 Nov 11;14(11):e31364. doi: 10.7759/cureus.31364. eCollection 2022 Nov.
4
Important Risk Factors in Patients with Nonvalvular Atrial Fibrillation Taking Dabigatran Using Integrated Machine Learning Scheme-A Post Hoc Analysis.使用集成机器学习方案对服用达比加群的非瓣膜性心房颤动患者的重要危险因素——一项事后分析
J Pers Med. 2022 May 6;12(5):756. doi: 10.3390/jpm12050756.
5
Management and 1-Year Outcomes of Patients With Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: Results From the Prospective GARFIELD - AF Registry.新发心房颤动合并慢性肾脏病患者的管理及 1 年转归：前瞻性 GARFIELD-AF 登记研究结果。
J Am Heart Assoc. 2019 Feb 5;8(3):e010510. doi: 10.1161/JAHA.118.010510.
6
Management of Anticoagulation in Patients with Atrial Fibrillation Undergoing PCI: Double or Triple Therapy?经皮冠状动脉介入治疗（PCI）的房颤患者抗凝管理：双联还是三联治疗？
Curr Cardiol Rep. 2018 Sep 26;20(11):110. doi: 10.1007/s11886-018-1045-0.
7
Efficacy of Statin Therapy Related to Baseline Renal Function in Patients with Rheumatic Heart Disease Undergoing Cardiac Surgery.他汀类药物治疗在风湿性心脏病心脏手术患者中与基线肾功能的相关性。
Biomed Res Int. 2018 Apr 15;2018:5972064. doi: 10.1155/2018/5972064. eCollection 2018.